Skip to main content
Journal cover image

Practice implications and recommendations for managing codeine misuse and dependence.

Publication ,  Other
Bergin, M; Norman, I; Foley, M; Harris, R; Rapca, A; Rich, E; Van Hout, M-C
Published in: Acta pharmaceutica (Zagreb, Croatia)
December 2015

Codeine, a weak opiate, requires increased pharmacovigilance relating to availability, heterogeneous nature of misuse, dependence and associated harm. A scoping review of literature on codeine was conducted using Arksey & O'Malley's framework (1). Databases searched included PubMed, EBSCO Host, Science Direct, EMBASE, PsycINFO, Cochrane library and Medline from 1994 to 2014. Follow-up search strategies involved hand searching and searching of pharmaceutical, health, medical and drug related websites. Initial zscreening identified 3,105 articles with 475 meeting the inclusion criteria. Eight broad categories organised the literature, data charting and qualitative synthesis. This paper presents implications for practice and makes recommendations to address these issues. Themes identified relate to raising public and practitioner awareness, risk management, dispensing practices and monitoring and surveillance of codeine. Evidence to inform law enforcement, drug surveillance, public health initiatives, harm reduction approaches, pharmacy, clinical and treatment practices is warranted.

Duke Scholars

Published In

Acta pharmaceutica (Zagreb, Croatia)

DOI

EISSN

1846-9558

ISSN

1330-0075

Publication Date

December 2015

Volume

65

Issue

4

Start / End Page

351 / 364

Related Subject Headings

  • Substance Abuse Detection
  • Risk Factors
  • Risk Assessment
  • Practice Patterns, Physicians'
  • Practice Guidelines as Topic
  • Physician's Role
  • Pharmacology & Pharmacy
  • Opioid-Related Disorders
  • Nonprescription Drugs
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bergin, M., Norman, I., Foley, M., Harris, R., Rapca, A., Rich, E., & Van Hout, M.-C. (2015). Practice implications and recommendations for managing codeine misuse and dependence. Acta pharmaceutica (Zagreb, Croatia). https://doi.org/10.1515/acph-2015-0040
Bergin, Michael, Ian Norman, Michelle Foley, Richard Harris, Anna Rapca, Eileen Rich, and Marie-Claire Van Hout. “Practice implications and recommendations for managing codeine misuse and dependence.Acta Pharmaceutica (Zagreb, Croatia), December 2015. https://doi.org/10.1515/acph-2015-0040.
Bergin M, Norman I, Foley M, Harris R, Rapca A, Rich E, et al. Practice implications and recommendations for managing codeine misuse and dependence. Vol. 65, Acta pharmaceutica (Zagreb, Croatia). 2015. p. 351–64.
Bergin, Michael, et al. “Practice implications and recommendations for managing codeine misuse and dependence.Acta Pharmaceutica (Zagreb, Croatia), vol. 65, no. 4, Dec. 2015, pp. 351–64. Epmc, doi:10.1515/acph-2015-0040.
Bergin M, Norman I, Foley M, Harris R, Rapca A, Rich E, Van Hout M-C. Practice implications and recommendations for managing codeine misuse and dependence. Acta pharmaceutica (Zagreb, Croatia). 2015. p. 351–364.
Journal cover image

Published In

Acta pharmaceutica (Zagreb, Croatia)

DOI

EISSN

1846-9558

ISSN

1330-0075

Publication Date

December 2015

Volume

65

Issue

4

Start / End Page

351 / 364

Related Subject Headings

  • Substance Abuse Detection
  • Risk Factors
  • Risk Assessment
  • Practice Patterns, Physicians'
  • Practice Guidelines as Topic
  • Physician's Role
  • Pharmacology & Pharmacy
  • Opioid-Related Disorders
  • Nonprescription Drugs
  • Humans